ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2α-Mediated Glycolysis is a research paper published in Molecular Therapy Nucleic Acids (2021). On theSindex it has a DataRank of 0.823. It has been cited 241 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.823
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Project 333 of Jiangsu Province
Grant: 2018055
Project 333 of Jiangsu Province
Grant: LGY2016002
Jiangsu Province's Key Provincial Talents Program
Grant: ZDRCA2016006
National Natural Science Foundation of China
Grant: 81602235
National Natural Science Foundation of China
Grant: 81772711
National Natural Science Foundation of China
Grant: 82072832
National Natural Science Foundation of China
Grant: 82073306
Priority Academic Program Development of Jiangsu Higher Education Institutions
FWCI
14.35
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 10 of ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer
Additional file 10 of ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer
Additional file 4 of ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer
Additional file 4 of ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer
Additional file 5 of ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer
Additional file 5 of ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer
Additional file 6 of ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer
Additional file 6 of ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer
Additional file 7 of ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer
Additional file 7 of ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer
Additional file 8 of ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer
Additional file 8 of ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer
Additional file 9 of ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer
Additional file 9 of ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer
Additional file 4 of Comprehensive analyses of glycolysis-related lncRNAs for ovarian cancer patients
Additional file 4 of Comprehensive analyses of glycolysis-related lncRNAs for ovarian cancer patients
Additional file 1 of Role of m6A writers, erasers and readers in cancer
Additional file 1 of Role of m6A writers, erasers and readers in cancer
Additional file 1 of ALKBH5-mediated m6A demethylation fuels cutaneous wound re-epithelialization by enhancing PELI2 mRNA stability
Additional file 1 of ALKBH5-mediated m6A demethylation fuels cutaneous wound re-epithelialization by enhancing PELI2 mRNA stability